At the IGTP TODAY
IGTP’s CARE Program held its fourth Annual Meeting on 22 October. The event brought together researchers and healthcare professionals to share projects and research activities, meet the new groups joining the program and review the work carried out so far.
Six leading institutions are joining forces across healthcare, research, education and innovation to create one of southern Europe's strongest cancer ecosystems. The new Consorci Oncològic Integral Nord Catalunya aims to achieve European certification as a Comprehensive Cancer Consortium and join the European network of excellence in oncology.
The III CARE Annual Meeting, held on 5 December at BCIN, brought together the cancer research community of the Can Ruti Campus for a day focused on scientific dialogue, interdisciplinarity and future strategy.
A team of researchers from IGTP and ICO has studied alterations in the KRAS gene in colorectal cancer by combining genomic analyses with a systematic review of targeted compounds and clinical trials. Their findings, published in the journal npj Precision Oncology, provide and updated overview to guide future advances in this cancer's treatment.
To mark World Cancer Day, the podcast of the IGTP dedicates its eighth episode to cancer research, with a special focus on the CARE program, an initiative that brings together healthcare professionals from the Can Ruti Campus to share knowledge and tools.
The second CARE Workshop, held on 9-10 October, brought together more than 70 researchers from across the cancer research community at the Can Ruti Biomedical Campus for two days of scientific exchange. The event served as a platform for sharing the current cancer research being developed on the Campus and fostering stronger connections among researchers.
A study led by researchers from the Germans Trias i Pujol Research Institute (IGTP) and Institut Català d’Oncologia (ICO) analysed peripheral blood samples from patients with metastatic colorectal cancer and identified a potential biomarker indicating the effectiveness of oxaliplatin-based treatment. The research has been published in the journal Biomedicine & Pharmacotherapy.
Researchers from B·ARGO and the Urological Tumour Unit at IGTP and ICO have led a study proposing a new therapeutic strategy based on a combination of kinase inhibitors for metastatic prostate cancer patients who have progressed on standard treatment. The study has been published in the journal Frontiers in Pharmacology.
CARE, the Translational Program in Cancer Research is the first transversal program promoted by the Germans Trias i Pujol Research Institute (IGTP), and it aims to become a bridge for researchers in the field of cancer who want to bring basic and clinical research together, so that the knowledge and the tools generated in the laboratory can benefit the patient.
